Correlation Between Eliem Therapeutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Eliem Therapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Pasithea Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Pasithea Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eliem and Pasithea is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Pasithea Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Pasithea Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.02 times less risky than Pasithea Therapeutics. The stock trades about -0.25 of its potential returns per unit of risk. The Pasithea Therapeutics Corp is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 2.12 in Pasithea Therapeutics Corp on August 30, 2024 and sell it today you would lose (0.09) from holding Pasithea Therapeutics Corp or give up 4.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 54.55% |
| Values | Daily Returns |
Eliem Therapeutics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Eliem Therapeutics |
| Pasithea Therapeutics |
Eliem Therapeutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Pasithea Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Pasithea Therapeutics vs. Pasithea Therapeutics Corp | Pasithea Therapeutics vs. Biofrontera Warrants | Pasithea Therapeutics vs. Lixte Biotechnology Holdings | Pasithea Therapeutics vs. Jasper Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |